Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 in Relapsed/Refractory Lymphoma
NCT01485536Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Luminespib in diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2012; status: terminated.
02
Drugs
Luminespib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01485536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485536.